Back to search results

A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry

Abroad (travel likely)Recruiting

Conditions

Hemolytic Disease of the Fetus and Newborn

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Riley Children s Hospital, Indianapolis, Indiana, United States

  • University of Cincinnati, Cincinnati, Ohio, United States

  • Oregon Health And Science University, Portland, Oregon, United States

  • Baylor College of Medicine, Houston, Texas, United States

  • The Royal Women's Hospital, Parkville, Australia

  • Mater Misericordiae Ltd, South Brisbane, Australia

  • Universitair Ziekenhuis Gent, Ghent, Belgium

  • Universitair Ziekenhuis Leuven, Leuven, Belgium

  • State University of Campinas Joao Bennini, Campinas, Brazil

  • Interdiszip Schwerpunkt fur Hamostaseologie, Giessen, Germany

  • Mangiagalli Clinic IRCCS Ca Granda Foundation Ospedale Maggiore Policlinico, Milan, Italy

  • Fondazione Policlinico Universitario A Gemelli IRCCS, Roma, Italy

  • Hosp Univ Vall D Hebron, Barcelona, Spain

  • Birmingham Women's Hospital, Birmingham, United Kingdom

Study leads

  • Janssen Research & Development, LLC Clinical Trial

    Study Director

    Janssen Research & Development, LLC

View source on ClinicalTrials.gov(opens in a new tab)